Health Care
Blog
Read the latest on the push for drug price controls
To Improve Drug Affordability Congress Should Fix the Payment System
Demanding that drug prices in the U.S. equal overseas prices is akin to demanding that the price of all expensive handbags should equal the prices for the knockoffs that people purchase from street vendors. Of course knockoff bags are cheaper. They violate the intellectual property rights of the bag’s maker, ...
Commentary
Colorado Gov. Polis’ new ‘study’ is a waste of time
The drive for single-payer health care won’t die. Gov. Jared Polis just signed legislation to spend $400,000 on a new “study” of how to bring government-run health care to the state. It’s a colossal waste of time and money. Decades of evidence from Canada and the United Kingdom show that ...
Commentary
Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick
The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted drugs at the lowest price in other industrialized countries. The president’s justification for the MFN is simple: Americans are ...
Commentary
Why sunblock in the U.S. is so much worse than in the E.U.
One in five Americans will develop skin cancer by age 70. Yet regulators in the United States have not approved sunscreens that can more effectively prevent the disease. Such safetyism makes little sense. Americans receive more diagnoses for skin cancer than for all other forms of cancer combined. It’s long ...
Blog
Read about the push for drug price controls
Trump and Biden Agree on Drug Pricing
Patients will pay dearly, as Michael Baker and Douglas Holtz-Eakin explain in two recent pieces for the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems. Biden signed the Inflation Reduction Act into law in 2022. It directs the feds to “negotiate” prices for a steadily increasing number of ...
Commentary
Republicans are right to reform Medicaid
House Republicans held the mark-up last week for their reconciliation package, which includes several significant reforms to Medicaid, the federal-state entitlement that provides health benefits to roughly one in five Americans. The package is not perfect. But it would restore some measure of fiscal sanity to the program by, among ...
Commentary
President Trump Hasn’t Given Up on Hospital Price Transparency
For markets to function efficiently, consumers need to know how much things cost. This is as true for eggs and milk as it is for medical care. And it was this very insight that motivated the rule that President Donald J. Trump implemented during his first term in 2019 ordering ...
Commentary
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs. The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without ...
Commentary
Is Era of Biomedical Innovation Wins Against Cancer Over?
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central ...
Commentary
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up. Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing ...
Read the latest on the push for drug price controls
To Improve Drug Affordability Congress Should Fix the Payment System
Demanding that drug prices in the U.S. equal overseas prices is akin to demanding that the price of all expensive handbags should equal the prices for the knockoffs that people purchase from street vendors. Of course knockoff bags are cheaper. They violate the intellectual property rights of the bag’s maker, ...
Colorado Gov. Polis’ new ‘study’ is a waste of time
The drive for single-payer health care won’t die. Gov. Jared Polis just signed legislation to spend $400,000 on a new “study” of how to bring government-run health care to the state. It’s a colossal waste of time and money. Decades of evidence from Canada and the United Kingdom show that ...
Trump Should Support Effective Drug Policy Reforms Not The MFN Gimmick
The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted drugs at the lowest price in other industrialized countries. The president’s justification for the MFN is simple: Americans are ...
Why sunblock in the U.S. is so much worse than in the E.U.
One in five Americans will develop skin cancer by age 70. Yet regulators in the United States have not approved sunscreens that can more effectively prevent the disease. Such safetyism makes little sense. Americans receive more diagnoses for skin cancer than for all other forms of cancer combined. It’s long ...
Read about the push for drug price controls
Trump and Biden Agree on Drug Pricing
Patients will pay dearly, as Michael Baker and Douglas Holtz-Eakin explain in two recent pieces for the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems. Biden signed the Inflation Reduction Act into law in 2022. It directs the feds to “negotiate” prices for a steadily increasing number of ...
Republicans are right to reform Medicaid
House Republicans held the mark-up last week for their reconciliation package, which includes several significant reforms to Medicaid, the federal-state entitlement that provides health benefits to roughly one in five Americans. The package is not perfect. But it would restore some measure of fiscal sanity to the program by, among ...
President Trump Hasn’t Given Up on Hospital Price Transparency
For markets to function efficiently, consumers need to know how much things cost. This is as true for eggs and milk as it is for medical care. And it was this very insight that motivated the rule that President Donald J. Trump implemented during his first term in 2019 ordering ...
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs. The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without ...
Is Era of Biomedical Innovation Wins Against Cancer Over?
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central ...
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up. Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing ...
